<DOC>
	<DOCNO>NCT00005062</DOCNO>
	<brief_summary>RATIONALE : Radiation therapy use high-energy x-ray kill tumor cell prevent spread cancer brain . It yet know standard-dose radiation therapy effective high-dose radiation therapy prevent spread limited-stage small cell lung cancer cell brain . PURPOSE : This randomized phase III trial compare two different regimen radiation therapy see well work treat patient limited-stage small cell lung cancer complete remission .</brief_summary>
	<brief_title>Radiation Therapy Patients With Limited-Stage Small Cell Lung Cancer Complete Remission</brief_title>
	<detailed_description>OBJECTIVES : - Compare high-dose versus standard-dose prophylactic cranial radiotherapy term incidence brain metastases overall disease free survival 2 year patient limited stage small cell lung cancer complete remission . - Evaluate quality life late sequela patient population treat regimen . OUTLINE : This randomize , multicenter study . Patients stratify accord participate center , age ( 60 vs 60 ) , interval start induction therapy date randomization ( 90 day less vs 91-180 day vs 180 day ) . Patients randomize one two treatment arm accord prophylactic cranial radiotherapy dose . - Arm I : Patients receive standard-dose prophylactic cranial radiotherapy ( 10 fractions/12 day ) . - Arm II : Patients receive high-dose prophylactic cranial radiotherapy administer 16 24 day base choice treatment center . - 18 fractions/24 day ( conventional radiotherapy ) OR - 24 fractions/16 day ( accelerate hyperfractionated radiotherapy ) Patients isolated brain failure may undergo radiotherapy . Quality life assess prior randomization , 6 month , 1 year , annually thereafter . Patients follow least every 6 month 2 year annually thereafter . PROJECTED ACCRUAL : A total 700 patient accrue study within 3 year .</detailed_description>
	<mesh_term>Lung Neoplasms</mesh_term>
	<mesh_term>Small Cell Lung Carcinoma</mesh_term>
	<criteria>DISEASE CHARACTERISTICS : Histologically proven limited stage small cell lung cancer Complete response induction therapy ( least chest xray ) Normal brain CT scan MRI le 1 month prior study No metastasis ( include ipsilateral lung metastasis malignant pleural effusion ) PATIENT CHARACTERISTICS : Age : 70 Performance status : WHO 02 Life expectancy : Not specify Hematopoietic : Not specify Hepatic : Not specify Renal : Not specify Cardiovascular : No prior cerebrovascular disease Other : No epilepsy require permanent oral medication No prior malignancy except skin cancer carcinoma situ cervix PRIOR CONCURRENT THERAPY : Biologic therapy : Not specify Chemotherapy : See Disease Characteristics No concurrent chemotherapy Endocrine therapy : Concurrent steroid allow Radiotherapy : Concurrent thoracic radiotherapy allow Surgery : Not specify Other No concurrent antitumoral agent</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>March 2014</verification_date>
	<keyword>limited stage small cell lung cancer</keyword>
</DOC>